IC 348

News and Video Search Results

News coverage

ROHM Semiconductor and Nanjing SemiDrive Technology Jointly Develop a Reference Design: Utilizing PMICs and SerDes ICs for SoC

GlobeNewswire 22 May 2024

Contributing to the proliferation of smart vehicle cockpits

Santa Clara, CA and Kyoto, Japan, May 22, 2024 (GLOBE..

Himax Technologies, Inc. Reports First Quarter 2024 Financial Results; Provides Second Quarter 2024 Guidance
GlobeNewswire 09 May 2024
CPI PROPERTY GROUP publishes financial results for 2023
EQS Group 29 Mar 2024
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
GlobeNewswire 22 Mar 2024
Peraso Announces Fourth Quarter and Full Year 2023 Results
Accesswire 18 Mar 2024

0 shares 1 views

You might like

IC 348 media coverage

ROHM Develops Automotive Primary LDOs: Leveraging Original QuiCur Technology to Achieve Industry-Leading Load Response Characteristics

GlobeNewswire 14 Mar 2024

Ensures stable output in automotive applications with high input voltage and significant load jumps

Santa Clara, CA and..

ROHM’s New Thermal Printhead Provides Clear Printing at High Speeds, Even on a Single-Cell Li-Ion Battery
GlobeNewswire 21 Feb 2024
Akoustis Reports Second Quarter FY24 Results
GlobeNewswire 13 Feb 2024
Himax Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Provides First Quarter 2024 Guidance
GlobeNewswire 06 Feb 2024
GSI Technology Receives Award from U.S. Air Force Research Laboratory to Demonstrate High-Data Computation Use Cases Leveraging Its Next-Generation APU
GlobeNewswire 03 Jan 2024

Advertisement

More coverage

NASA's James Webb Space Telescope breaks another record, discovering the smallest star-like object astronomers have ever seen

Upworthy 23 Dec 2023

Central portion of the star cluster IC 348 as seen by JWST. NASA, ESA, CSA, STScI, K. Luhman (Penn State University), and C. Alves..

NASA’s Webb Identifies Tiniest Free-Floating Brown Dwarf
Eurasia Review 13 Dec 2023
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
GlobeNewswire 11 Dec 2023
Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
GlobeNewswire 06 Dec 2023
A prominent protostar in Perseus
ESA 28 Nov 2023